Modāsa, India
Modāsa, India

Time filter

Source Type

Discover how disaster drives innovation as the healthcare of catastrophes is discussed at this year's event. -- A trio of experts will speak at the Mensa Foundation's 2017 Colloquium July 5 at the Diplomat Resort in Hollywood, Fla., this year examining the Health Care of Catastrophes. Dr. Sheri Fink, Dr. Joseph Ibrahim and Dr. Michael Osterholm will explore the complex care challenges that the medical community faces as it takes on hurricanes, mass shootings and other manmade and natural disasters.Dr. Fink's coverage of life-or-death decisions made at a Hurricane Katrina-besieged hospital won the 2010 Pulitzer Prize for investigative reporting. Her expertise on the health care of disasters extends beyond her award-winning reporting on New Orleans' Memorial Hospital. The work by Dr. Fink and hercolleagues on the 2014 West Africa Ebola crisis was recognized with the 2015 Pulitzer for international reporting.Dr. Ibrahim serves as trauma medical director at Orlando Regional Medical Center, overseeing Central Florida's only Level 1 trauma center. Ibrahim's team was key in responding and treating the victims of the worst mass shooting by a single assailant in U.S. history, the 2016 Pulse Nightclub shooting in Orlando, Fla.Dr. Osterholm, director of the Center for Infectious Disease Research and Policy, has been a national leader detailing the growing concern regarding the use of biological agents as catastrophic weapons targeting civilian populations. After 9/11, Dr. Osterholm served as Special Adviser to the secretary of the U.S. Department of Health and Human Services on issues regarding public health preparedness.Drs. Ibrahim, Fink and Osterholm will be accompanied by other experts who will discuss how working in exceptional circumstances can lead to exceptional ideas and solutions.Visitto register and learn more about Colloquium 2017, sponsored by the Mensa Education & Research Foundation.The Mensa Education & Research Foundation benefits society by inspiring and empowering intellectually gifted people. For more than 40 years the Foundation has supported the best and brightest through scholarships and awards. It encourages research and intellectual inquiry through theand its various Colloquiums. Governed by a volunteer Board of Trustees, the Mensa Foundation is a 501(c)(3) organization and is funded by American Mensa, Mensa members and other charitable donations. To learn more about the Foundation, visit mensafoundation.org.


-- Eurotech (http://www.eurotech.com), a leading provider of embedded systems, Machine-to-Machine (M2M) platforms and Internet of Things (IoT) solutions, today announced that it has signed a partnership agreement withVintech (http://www.vintechin.com/), trusted service provider of IT Products, Services & Solutions, to design and deliver end-to-end solutions for IIoT and Smart Cities.Eurotech selected Vintech as first partner to increase its presence in the Indian market for the year-long experience acquired in the IT industry and for its successful customer centric approach.Chintamani Lele, Director at Vintech, commented "Team Vintech had first interaction with Team Eurotech a year ago, and immediately realised, that looking at the future trends and prospects of IoT, they must have a technology partner like Eurotech for the Indian markets. With Eurotech's technology products like Multi-service IoT Gateways (http://www.eurotech.com/en/products/devices/iot+gateways), Passenger Counters ( http://www.eurotech.com/ en/products/ mobile+devices/ people... ), Environmental Sensors ( http://www.eurotech.com/ en/products/ devices/environmental... ) and the Everyware Cloud IoT integration platform, Vintech aims to address the fast growing market of Industrial IoT and Smart City Projects in the first phase. It aims to take the Eurotech technology across the length and breadth of its customer base in India, and also in newer markets.""Vintech thanks to his role as leading IT service provider is the ideal partner to establish Eurotech presence in the Indian market" said Giuseppe Surace, Eurotech's CP&MO. "This partnership is a further confirmation of Eurotech leadership in the IoT industry on a global scale and its willingness to continue to provide innovative end-to-end horizontal solutions for different verticals."Eurotech (ETH:IM) is a global company that designs, creates and delivers full Internet of Things solutions, including services, software and hardware to leading systems integrators and enterprises large and small. With Eurotech solutions in place, clients have access to the latest open source and standardized software stacks, flexible and rugged Multi-service IoT Gateways and sophisticated sensors to bring actionable data from the field into business operations. Working with world-class ecosystem partners, Eurotech delivers on the promise of the Internet of Things either from end to end, or with best in class building blocks, including device and data management, connectivity and communication platform, intelligent edge devices and smart objects following business models that fit today's business world. Learn more about Eurotech at www.eurotech.com.Vintech Electronic Systems Pvt. Ltd. has emerged as one of the most trusted service provider of IT Products, Services & Solutions. A pioneering organization with an experience of more than 20 years, Vintech has been successful in maintaining a customer centric approach in all its ventures. From systems integration to post-sales support, Vintech offers a wide range of services and solutions. The company is run by a team of highly qualified and experienced industry experts. Today, Vintech Customer base exceeds 2500 customers from diverse segments like IT & ITES, Manufacturing, Banking & Finance, Government & Defense, Education & Research, Healthcare & Hospitality. Vintech aims to be the most preferred IT solutions and services partner across India in coming years. To add to this, Vintech has now started diversifying into the future trends of IoT and Data Analytics. With strategic joint ventures and associations, it offers end-to-end solutions for IIoT, Smart City Projects and Healthcare customers.


Eurotech and Vintech Partner up to Provide Industrial IoT and Smart City Solutions in India Amaro, Italy, April 21, 2017 --( Eurotech selected Vintech as first partner to increase its presence in the Indian market for the year-long experience acquired in the IT industry and for its successful customer centric approach. Chintamani Lele, Director at Vintech, commented “Team Vintech had first interaction with Team Eurotech a year ago, and immediately realised, that looking at the future trends and prospects of IoT, they must have a technology partner like Eurotech for the Indian markets. With Eurotech's technology products like Multi-service IoT Gateways, Passenger Counters, Environmental Sensors and the Everyware Cloud IoT integration platform, Vintech aims to address the fast growing market of Industrial IoT and Smart City Projects in the first phase. It aims to take the Eurotech technology across the length and breadth of its customer base in India, and also in newer markets.” “Vintech thanks to his role as leading IT service provider is the ideal partner to establish Eurotech presence in the Indian market,” said Giuseppe Surace, Eurotech’s CP&MO. “This partnership is a further confirmation of Eurotech leadership in the IoT industry on a global scale and its willingness to continue to provide innovative end-to-end horizontal solutions for different verticals.” About Eurotech Eurotech (ETH:IM) is a global company that designs, creates and delivers full Internet of Things solutions, including services, software and hardware to leading systems integrators and enterprises large and small. With Eurotech solutions in place, clients have access to the latest open source and standardized software stacks, flexible and rugged Multi-service IoT Gateways and sophisticated sensors to bring actionable data from the field into business operations. Working with world-class ecosystem partners, Eurotech delivers on the promise of the Internet of Things either from end to end, or with best in class building blocks, including device and data management, connectivity and communication platform, intelligent edge devices and smart objects following business models that fit today’s business world. Learn more about Eurotech at www.eurotech.com. Vintech Electronic Systems Pvt. Ltd. Vintech Electronic Systems Pvt. Ltd. has emerged as one of the most trusted service provider of IT Products, Services & Solutions. A pioneering organization with an experience of more than 20 years, Vintech has been successful in maintaining a customer centric approach in all its ventures. From systems integration to post-sales support, Vintech offers a wide range of services and solutions. The company is run by a team of highly qualified and experienced industry experts. Today, Vintech Customer base exceeds 2500 customers from diverse segments like IT & ITES, Manufacturing, Banking & Finance, Government & Defense, Education & Research, Healthcare & Hospitality. Vintech aims to be the most preferred IT solutions and services partner across India in coming years. To add to this, Vintech has now started diversifying into the future trends of IoT and Data Analytics. With strategic joint ventures and associations, it offers end-to-end solutions for IIoT, Smart City Projects and Healthcare customers. Amaro, Italy, April 21, 2017 --( PR.com )-- Eurotech, a leading provider of embedded systems, Machine-to-Machine (M2M) platforms and Internet of Things (IoT) solutions, today announced that it has signed a partnership agreement with Vintech, trusted service provider of IT Products, Services & Solutions, to design and deliver end-to-end solutions for IIoT and Smart Cities.Eurotech selected Vintech as first partner to increase its presence in the Indian market for the year-long experience acquired in the IT industry and for its successful customer centric approach.Chintamani Lele, Director at Vintech, commented “Team Vintech had first interaction with Team Eurotech a year ago, and immediately realised, that looking at the future trends and prospects of IoT, they must have a technology partner like Eurotech for the Indian markets. With Eurotech's technology products like Multi-service IoT Gateways, Passenger Counters, Environmental Sensors and the Everyware Cloud IoT integration platform, Vintech aims to address the fast growing market of Industrial IoT and Smart City Projects in the first phase. It aims to take the Eurotech technology across the length and breadth of its customer base in India, and also in newer markets.”“Vintech thanks to his role as leading IT service provider is the ideal partner to establish Eurotech presence in the Indian market,” said Giuseppe Surace, Eurotech’s CP&MO. “This partnership is a further confirmation of Eurotech leadership in the IoT industry on a global scale and its willingness to continue to provide innovative end-to-end horizontal solutions for different verticals.”About EurotechEurotech (ETH:IM) is a global company that designs, creates and delivers full Internet of Things solutions, including services, software and hardware to leading systems integrators and enterprises large and small. With Eurotech solutions in place, clients have access to the latest open source and standardized software stacks, flexible and rugged Multi-service IoT Gateways and sophisticated sensors to bring actionable data from the field into business operations. Working with world-class ecosystem partners, Eurotech delivers on the promise of the Internet of Things either from end to end, or with best in class building blocks, including device and data management, connectivity and communication platform, intelligent edge devices and smart objects following business models that fit today’s business world. Learn more about Eurotech at www.eurotech.com.Vintech Electronic Systems Pvt. Ltd.Vintech Electronic Systems Pvt. Ltd. has emerged as one of the most trusted service provider of IT Products, Services & Solutions. A pioneering organization with an experience of more than 20 years, Vintech has been successful in maintaining a customer centric approach in all its ventures. From systems integration to post-sales support, Vintech offers a wide range of services and solutions. The company is run by a team of highly qualified and experienced industry experts. Today, Vintech Customer base exceeds 2500 customers from diverse segments like IT & ITES, Manufacturing, Banking & Finance, Government & Defense, Education & Research, Healthcare & Hospitality. Vintech aims to be the most preferred IT solutions and services partner across India in coming years. To add to this, Vintech has now started diversifying into the future trends of IoT and Data Analytics. With strategic joint ventures and associations, it offers end-to-end solutions for IIoT, Smart City Projects and Healthcare customers. Click here to view the list of recent Press Releases from Eurotech


News Article | March 16, 2016
Site: cen.acs.org

A diverse team of global experts has been selected to lead ACS Omega, the American Chemical Society’s newest open access journal publishing peer-reviewed articles. Based in the Americas, Europe, India, and China, the editors not only represent key geographic regions of active R&D, they also bring expertise from four distinct scientific areas of interest. The new editors are Cornelia Bohne, a professor of chemistry at the University of Victoria in Canada; Krishna Ganesh, director of the Indian Institute of Science Education & Research in India; Luis Liz-Marzán, Ikerbasque research professor and scientific director at CIC biomaGUNE in Spain; and Deqing Zhang, director of the Institute of Chemistry, Chinese Academy of Sciences, in China. Bohne’s research focuses on developing the fundamental understanding of the dynamics of supramolecular systems and on the application of this knowledge to functional supramolecular materials. Ganesh is an expert in modified DNA and peptide-nucleic acids as novel cell-penetrating agents. As the first (founding and serving) director of IISER, Ganesh has built a unique, interdisciplinary infrastructure in which teaching and education are wholly integrated into state-of-the-art research. Liz-Marzán’s research focuses on nanoparticle synthesis and assembly, nanoplasmonics, and the development of nanoparticle-based sensing and diagnostic tools. He most recently served as a senior editor of the ACS journal Langmuir. Zhang’s research focuses on organic functional materials involving synthesis of organic functional molecules, spectroscopic studies, characterizations of self-assembly structures and optoelectronic properties, as well as applications for chemo/biosensing and imaging. “The ACS Omega editors have themselves authored in aggregate more than 850 peer-reviewed research articles, book chapters, and patents,” says Penelope Lewis, director of editorial and new product development in ACS Publications. “Their prolific publishing records and academic and professional achievements set the foundation for a team that will define and lead the editorial vision for the journal, drawing on a geographically diverse editorial board they will soon enlist—to be composed of active researchers with wide-ranging expertise and scientific backgrounds across chemistry, chemical engineering, and allied interdisciplinary scientific fields.” ACS Omega will begin accepting research submissions in April 2016 and will publish its first articles online early this summer.


ARLINGTON, VA - February 16, 2017 - Joe Biden, 47th Vice President of the United States, will receive Research!America's Gordon and Llura Gund Leadership Award for his commitment to accelerating cancer research as the driving force behind the White House Cancer Moonshot. The Cancer Moonshot, and now the Biden Cancer Initiative, aim to speed the pace in which effective therapies are made available to patients and improve efforts to prevent and detect cancer at an early stage. The Gund Award is presented to individuals who have made a significant contribution to increasing the level of advocacy for medical or health research at the local, state or national level. Biden, who expressed hope in doubling the rate of progress toward ending cancer as we know it, will be honored at the 21st Annual Advocacy Awards at the Andrew W. Mellon Auditorium in Washington, D.C. The awards dinner, to be held March 15, brings more than 400 leaders from government, industry, academia and health advocacy organizations together to recognize top medical and health research advocates who have made an impact in advancing the nation's commitment to research. "The energy behind the Cancer Moonshot is a result of Joe Biden's unflinching determination to prevent and halt the progression of cancer," said Governor Mike Castle, Research!America Board of Directors Vice Chair. "He's a true visionary who has the capacity to marshal the necessary brainpower and resources to help us make greater strides in cancer research." Cancer is expected to take the lives of more than 600,000 people in the U.S. this year and an estimated 1.6 million new cancer cases will be diagnosed. Biden's son, former Delaware Attorney General Beau Biden, died from brain cancer in 2015. Under Biden's leadership, the White House Cancer Moonshot Task Force facilitated novel, innovative and impactful collaborations among twenty government agencies, departments and White House offices, and over 70 private sector collaborations designed to achieve a decade's worth of progress in five years in the prevention, diagnosis and treatment of cancer. Biden also helped lead the effort to pass the 21st Century Cures Act which provides $1.8 billion over seven years for the Cancer Moonshot's scientific priorities. "Biden reinvigorated the scientific community with his bold vision for putting cancer research on a faster track, bringing renewed hope for patients and their loved ones," said Mary Woolley, president and CEO, Research!America. "We are honored to recognize his extraordinary achievements and perseverance in the fight against such a complex, deadly disease." In recognition for his public service, Biden was awarded the Presidential Medal of Freedom, the nation's highest civilian honor, with distinction. The Biden Foundation, announced in February 2017, will build upon Joe Biden's and Dr. Jill Biden's lifelong commitment to protect and advance the rights and opportunities of all people through educational programming and public policy analysis. The Foundation's areas of focus include: The Cancer Initiative, foreign policy, community colleges and military families, protecting children, equality, ending violence against women and strengthening the middle class. Biden will also serve as the Benjamin Franklin Presidential Practice Professor at the Penn Biden Center for Diplomacy and Global Engagement at the University of Pennsylvania, and lead the Biden Institute based at the University of Delaware, a research and policy center focused on public policy, economic reform and civil rights, among other issues. He has been named chair of the board of trustees of the National Constitution Center, a nonpartisan museum focused on educating and informing American people about the Constitution. Other 2017 Research!America Advocacy Award honorees are Senator Lamar Alexander (R-TN) who will receive the Edwin C. Whitehead Award for Medical Research Advocacy; Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH, who is the recipient of the Legacy Award; Kathy Bates, award-winning actress and Lymphatic Education & Research Network (LE&RN) spokesperson; Phillip A. Sharp, Ph.D., Nobel Laureate and Institute Professor at the Massachusetts Institute of Technology; Leland H. Hartwell, Ph.D., Nobel Laureate and co-director of the Center for Sustainable Health at Arizona State University's Biodesign Institute and Virginia G. Piper Chair of Personalized Medicine; and The Lupus Foundation of America. The annual Research!America Advocacy Awards program was established in 1996 by the Board of Directors to honor outstanding advocates for medical, health and scientific research. Recognized individuals and organizations are those whose extraordinary leadership efforts have been effective in advancing our nation's commitment to medical, health and other scientific research. This year the awards event will take place on March 15, 2017, at the Andrew W. Mellon Auditorium in Washington, D.C. For more information, visit http://www. . Research!America is the nation's largest nonprofit public education and advocacy alliance working to make research to improve health a higher national priority. Founded in 1989, Research!America is supported by member organizations representing 125 million Americans. Visit http://www. .


— The high degree of accuracy of manufactured products from optimal use of raw materials is a major factor bolstering the global 3D printing market. Using this technique, multiple materials can be employed for printing same object allowing to customize the product. In addition, it provides ample of savings on tooling over the traditional manufacturing techniques. A significant reduction in manufacturing cost and time can be achieved by applying 3D printing technique in production along with efficient logistics management. Additionally, human errors generated during development of an object can be minimized, thereby, delivering high quality output. The throughput of products is expected to increase post-implementation of 3D printing technique in manufacturing processes. Browse market data tables and in-depth TOC of the 3D Printing Market to 2025 @ http://www.theinsightpartners.com/reports/3d-printing-market High production cost for an individual user is one of the factor hindering the global 3D printing market. Additionally, the setup and software required for implying 3D printing is costly, thereby further restricting it's to a limited number of users. Additionally, the production of large objects consumes more time with 3D printing as compared to traditional manufacturing methods showing the inability of a 3D printer to produce in bulk in quick time, thereby restricting the global 3D printing market. The lack of skilled labor capable of operating 3D printing devices coupled with the lack of assistance from channel partners, thereby making it difficult for unskilled labor to operate the device, hinders the global 3D printing market. The 3D printing market is at a nascent stage and is expected to expand at a robust rate as various sectors, such as healthcare & medical, automotive & aerospace, are endorsing this technology. Also, 3D printing technology offers numerous benefits over the traditional manufacturing techniques, and is thus expected to replace traditional techniques during the forecast period. Increasing development of 3D scan and 3D print technology for better print quality are further expected to catalyze the global 3D printing market. The global 3D printing market is segmented on basis of technology into stereolithography (SL), jetting technology, laser sintering, electron beam melting (EBM), deposition modelling, laminated object manufacturing (LOM), and three dimensional printing (3DP). The market is further divided based on material used as polymers, metals & alloys, ceramics, and others (wax, lay wood, plastic film, metal foil and paper). Additionally, the global 3D printing market is segmented based on applications, namely: aerospace industry, automotive industry, consumer products, education & research, government & defense, healthcare industry, industrial/business machines and other applications (such as architecture, forensics, arts, and fashion among others). Geographically, the global 3D printing market is divided into five major regions, namely: North America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA), and South America (SAM). Currently, North America dominates the global 3D printing market owing to rapid adoption of this technology in healthcare & medical, aerospace and automotive industries. A significant growth in APAC is expected due to increasing demand of 3D printing in industrial segments. Some of the key players of the global 3D printing market include 3D Systems Inc., Eos GmbH Electro Optical Systems, Arcam AB, Hoganas AB, Organovo Holdings, Inc., Autodesk, Inc., SLM Solutions GmbH, Optomec, Inc., Exone GmbH, Ponoko Limited, Stratasys Ltd., Concept Laser GmbH, Solidscape Inc., and Voxeljet AG among others. Few Key Points from Table of Content Global 3D Printing Market Revenue and Forecasts to 2025 - Technology • Stereo Lithography (SL) • Jetting Technology • Laser Sintering • Electron Beam Melting (EBM) • Deposition Modelling • Laminated Object Manufacturing • Three Dimensional Printing (3DP) Global 3D Printing Market Revenue and Forecasts to 2025 - Material • Polymers • Metals & Alloys • Ceramics • Others (Wax, Lay Wood, Plastic Film, Metal Foil, Paper, etc.) Global 3D Printing Market Revenue and Forecasts to 2025 - Application • Aerospace • Automotive • Consumer Products • Education & Research • Government & Defense • Healthcare Industry • Industrial/Business Machines • Others (Architecture, Forensics, Arts, Fashion, etc.) Global 3D Printing Market Revenue and Forecasts to 2025 - Geographical Analysis • North America • Europe • Asia Pacific (APAC) • Middle East & Africa (MEA) • South America (SAM) Inquire about discount on this report @ http://www.theinsightpartners.com/discount/TIPTE100000133 About The Insight Partners: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, and Telecommunication industries. For more information, please visit http://www.theinsightpartners.com/


Research and Markets has announced the addition of the "Global Haptics Technology Market Analysis & Trends - Industry Forecast to 2025" report to their offering. The Global Haptics Technology Market is poised to grow at a CAGR of around 17.6% over the next decade to reach approximately $31.8 billion by 2025. Some of the prominent trends that the market is witnessing include increasing adoption of haptic technology in smartphones, rising market for gaming applications, and advanced technological developments. Based on Component the market is categorized into input devices, software, drivers, microcontrollers, sensors, touch screens, actuators, and other components. Further, actuators segmented by electroactive polymer actuators, eccentric rotating mass (ERM), piezoelectric actuator, and linear resonant actuators (LRAs). By technology the market is segmented by surface acoustic wave (SAW), resistive, optical imaging, and capacitive. On basis of feedback the market is segmented by force feedback, tactile feedback. Depending on the application the market is segregated into education & research, defense, consumer electronics, gaming, automotive & transportation, healthcare, engineering, and other applications. - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2025 - Market opportunities and recommendations for new investments 3 Market Overview 3.1 Current Trends 3.1.1 Increasing adoption of haptic technology in smartphones 3.1.2 Rising market for gaming applications 3.1.3 Advanced technological developments 3.1.4 Growth Opportunities/Investment Opportunities 3.2 Drivers 3.3 Constraints 3.4 Industry Attractiveness 4 Haptics Technology Market, By Component 4.1 Input Devices 4.1.1 Input Devices Market Forecast to 2025 (US$ MN) 4.2 Software 4.2.1 Software Market Forecast to 2025 (US$ MN) 4.3 Drivers 4.3.1 Drivers Market Forecast to 2025 (US$ MN) 4.4 Microcontrollers 4.4.1 Microcontrollers Market Forecast to 2025 (US$ MN) 4.5 Sensors 4.5.1 Sensors Market Forecast to 2025 (US$ MN) 4.6 Touch screens 4.6.1 Touch screens Market Forecast to 2025 (US$ MN) 4.7 Actuators 4.7.1 Actuators Market Forecast to 2025 (US$ MN) 4.7.1.1 Electroactive Polymer Actuators 4.7.1.1.1 Electroactive Polymer Actuators Market Forecast to 2025 (US$ MN) 4.7.1.2 Eccentric Rotating Mass (ERM) 4.7.1.2.1 Eccentric Rotating Mass (ERM) Market Forecast to 2025 (US$ MN) 4.7.1.3 Piezoelectric Actuator 4.7.1.3.1 Piezoelectric Actuator Market Forecast to 2025 (US$ MN) 4.7.1.4 Linear Resonant Actuators (LRAs) 4.7.1.4.1 Linear Resonant Actuators (LRAs) Market Forecast to 2025 (US$ MN) 4.8 Other Components 4.8.1 Other Components Market Forecast to 2025 (US$ MN) 5 Haptics Technology Market, By Technology 5.1 Surface acoustic wave (SAW) 5.1.1 Surface acoustic wave (SAW) Market Forecast to 2025 (US$ MN) 5.2 Resistive 5.2.1 Resistive Market Forecast to 2025 (US$ MN) 5.3 Optical imaging 5.3.1 Optical imaging Market Forecast to 2025 (US$ MN) 5.4 Capacitive 5.4.1 Capacitive Market Forecast to 2025 (US$ MN) 6 Haptics Technology Market, By Feedback 6.1 Force Feedback 6.1.1 Force Feedback Market Forecast to 2025 (US$ MN) 6.2 Tactile Feedback 6.2.1 Tactile Feedback Market Forecast to 2025 (US$ MN) 7 Haptics Technology Market, By Application 7.1 Education & Research 7.1.1 Education & Research Market Forecast to 2025 (US$ MN) 7.2 Defense 7.2.1 Defense Market Forecast to 2025 (US$ MN) 7.3 Consumer Electronics 7.3.1 Consumer Electronics Market Forecast to 2025 (US$ MN) 7.4 Gaming 7.4.1 Gaming Market Forecast to 2025 (US$ MN) 7.5 Automotive & Transportation 7.5.1 Automotive & Transportation Market Forecast to 2025 (US$ MN) 7.6 Healthcare 7.6.1 Healthcare Market Forecast to 2025 (US$ MN) 7.7 Engineering 7.7.1 Engineering Market Forecast to 2025 (US$ MN) 7.8 Other Applications 7.8.1 Other Applications Market Forecast to 2025 (US$ MN) 8 Haptics Technology Market, By Geography - Force Dimension - Geomagic, Inc. - Haption S.A. - Imagis Co., Ltd. - Immersion Corporation - Johnson Electric Holdings Ltd. - Microchip Technologies, Inc. - National semiconductor - On Semiconductor Corporation - Precision Microdrives Ltd. - Samsung Electronics - Senseg Oy - SMK Corporation - Synaptics Incorporated - Texas Instruments, Inc. - Ultrahaptics For more information about this report visit http://www.researchandmarkets.com/research/4r6q3w/global_haptics


TORONTO, ONTARIO--(Marketwired - Oct. 27, 2016) - Arch Biopartners, Inc., (Arch or the Company) (TSX VENTURE:ACH)(OTCBB:FOIFF) today announced it has agreed to sponsor Dr. Ralph Panos and his clinical trial team at the Cincinnati Veterans Affairs Medical Center (CVAMC) to prepare a phase I and phase II human trial protocol and an application to conduct investigator initiated trials evaluating the safety and efficacy of AB569. "We are excited to support Dr. Panos and his team to prepare an application to perform the first human trials for AB569, which we believe will validate the clinical potential of AB569 and may provide an accelerated route toward a New Drug Application with the FDA," said Richard Muruve, CEO of Arch. Under the terms of the agreement, which was facilitated through the Cincinnati Education and Research for Veteran's Foundation, Dr. Panos will draft the clinical trial protocol ("Protocol") for phase I and II human trials. Once completed, the Protocol will form part of an application to conduct an investigator initiated trial at CVAMC with Dr. Panos as the principal investigator. The application is expected to be submitted to the internal review board (IRB) of the CVAMC by December, 2016. IRB feedback is anticipated before January, 2017 and the trial is expected to start immediately upon an approval to proceed. Once the Phase I clinical trial is completed with positive safety results, the study will immediately transition to a Phase II clinical trial of AB569 in patients with chronic obstructive pulmonary disease (COPD) that have severe bacterial lung infections that are resistant to antibiotics. Separately, Catalent Pharma Solutions in North Carolina continues to make preparations at its facilities to provide a GMP supply of AB569 which is expected to be ready for clinical trial purposes by January, 2017. Dr. Ralph J. Panos, MD, Chief of Medicine, Cincinnati Veterans Affairs Medical Center - Dr. Panos is the Chief of Medicine and Medical Director of the Veterans Integrated Service Network 10 TeleICU Program at the Cincinnati Veterans Affairs Medical Center. Dr. Panos obtained undergraduate and medical degrees from Brown University; performed his internal medical residency and chief residency at the University of Maryland in Baltimore; and, completed a pulmonary fellowship at the University of Colorado. His academic appointments include Northwestern University, Penn State, and now the University of Cincinnati. He has worked at the CVAMC for over 10 years holding positions as the Chief of the Pulmonary, Critical Care, and Sleep Medicine Section and Associate Chief of Staff for Research and Development. He serves as President and Chairman of the Board of the Cincinnati Education & Research for Veterans Foundation (CERV). Dr. Panos is Professor of Medicine, Pulmonary, Critical Care, and Sleep Medicine, and Associate Chief of Medicine for Veterans Affairs, Department of Internal Medicine, University of Cincinnati College of Medicine. Dr. Panos has been engaged in pulmonary and critical care research from both basic science and clinical perspectives for approximately 20 years and has been involved extensively in clinical studies of COPD for the past 5 years. His clinical trial team has performed a series of clinical investigations that characterize the population of Veterans with COPD at the CVAMC and these studies led to the development and funding of an innovative, comprehensive COPD management program at the CVAMC. In addition, Dr. Panos's clinic has been a center for NIH (LOTT), VA (Breath), and industry sponsored trials in COPD with a very successful history of study recruitment and enrollment. About AB569 and Anti-biotic resistant airway infections in COPD and CF patients AB569 was invented by Dr. Daniel Hassett, Professor at the University of Cincinnati College of Medicine, to treat antibiotic resistant bacterial lung infections, which is a significant problem for patients with either cystic fibrosis ("CF") or COPD. AB569 is also a candidate treatment for antibiotic resistant urinary tract infections, gastrointestinal infections and skin infections. AB569 has been exclusively licensed to Arch by the University of Cincinnati. AB569, as a bactericidal compound, constitutes an innovative potential treatment for dealing with pulmonary bacterial infections that are resistant to traditional antibiotics. In pre-clinical studies, AB569 has demonstrated significant ability to kill many types of Gram-negative and Gram-positive bacteria. Cystic fibrosis patients are predisposed to bacterial lung infections due to abnormal mucus production in the lungs and airways. In particular, Pseudomonas aeruginosa infects 40% of CF patients between the ages of 6 and 10 years of age. By the age of 17, the frequency of infection increases to 60% and reaches approximately 75% of all CF patients between the ages of 25 and 34. The mucoid form of P. aeruginosa is a very challenging infection to treat due to its high resistance to both antibiotics and phagocyte-mediated killing. Once patients present with the mucoid form of P. aeruginosa, their overall lung function precipitously declines, resulting in a poor overall prognosis. Like CF patients, people with COPD have compromised immune systems and respiratory conditions that are vulnerable to chronic bacterial infections that often resist antibiotics. COPD is a major health problem worldwide and its prevalence is increasing (315,000,000 patients world-wide), ranked by the World Health Organization as the third leading cause of death. COPD is a general term to describe progressive lung diseases which includes chronic bronchitis, emphysema, and non-reversible asthma. Most cases are caused by inhaling pollutants, usually from smoking or exposure to lung pollutants in the workplace. Arch Biopartners Inc. is focused on the development of innovative technologies that have the potential to make a significant medical or commercial impact. Arch works closely with the scientific community, universities and research institutions to advance and build the value of select preclinical technologies, develop the most promising intellectual property, and create value for its investors. Arch has established a diverse portfolio that includes AB569, a potential new treatment for antibiotic resistant bacterial infections; Metablok, a potential treatment for sepsis and cancer metastasis; MetaMx, which targets elusive brain tumor initiating cells; and, 'Borg' peptide coatings that increase corrosion resistance and decrease biofilm on various medical grade metals and plastics. For more information on Arch Biopartners, other public documents Arch has filed on SEDAR and its technologies including, please visit www.archbiopartners.com. The Company currently has 53,849,679 common shares outstanding. All statements, other than statements of historical fact, in this news release are forward looking statements that involve various risks and uncertainties, including, without limitation, statements regarding the future plans and objectives of the Company. There can be no assurance that such statements will prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. The Company assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Receive press releases from Performance Architects, Inc.: By Email Performance Architects’ Kirby Lunger Joins the Board of Directors for the OAUG Oracle Business Intelligence & Big Data SIG Boston, MA, February 17, 2017 --( "I am honored to expand my service to the OAUG and Oracle community on the OAUG Oracle Business Intelligence & Big Data SIG board of directors," said Kirby Lunger. “The Performance Architects team works extensively with business analytics and big data initiatives across several industries, and this SIG is a wonderful forum for professional networking and sharing, as well as learning from Oracle product management and marketing, customers, and partners.” “We’re excited to have Kirby join the Board of the Oracle Business Intelligence & Big Data SIG,” said Jay Canupp, Board Chair for the Oracle Business Intelligence & Big Data SIG. “Her industry experience in business analytics, BI and data discovery, coupled with her leadership background in related topic areas at the OAUG, will allow us to continue to expand our reach and grow our relationships within the Oracle community.” About Performance Architects, Inc. Performance Architects, Inc. is a business and technology consulting company that partners with our clients to initiate and sustain significant improvements in enterprise performance. We offer business consulting to help establish and enhance performance management processes either across your organization or within specific functions; technology consulting to make sure that the appropriate data and information are available to make the best decisions to improve performance; and industry expertise to provide the context for what your organization should do to lead within your segment. Performance Architects is a Platinum level and Cloud Standard member of the Oracle PartnerNetwork (OPN), with Specializations in Oracle BI Foundation (BICS), Oracle Essbase, Oracle Hyperion Planning (PBCS), Oracle Hyperion Financial Management (HFM), Oracle Accelerate for Midsize Companies, Education & Research (Higher Education) and Life Sciences. Our team has worked with Oracle EPM (Hyperion) products since these products were launched, and maintains deep experience with the entire Oracle Business Intelligence (OBI) suite and related data discovery solutions. Performance Architects' services in this arena include implementing or augmenting financial applications, reporting and analysis solutions, and underlying technologies both organization-wide or within specific functional areas such as Finance, IT, HR, Sales & Marketing, and Operations. More information about Performance Architects is available at www.performancearchitects.com, or follow Performance Architects on Twitter, Facebook, LinkedIn and YouTube. About the Oracle Applications Users Group (OAUG®) Founded in 1990, the Oracle Applications Users Group (OAUG) is an independent, global, member-led organization that maximizes customers’ investment in Oracle and partner solutions. The organization serves as an advocate to Oracle for companies worldwide and represents users of Oracle Applications products including Oracle Applications Cloud, Oracle E-Business Suite, Oracle Enterprise Performance Management (including Oracle Hyperion), Oracle’s Primavera Enterprise Project Portfolio Management, Oracle Communications, Oracle Customer Experience Cloud, and others. The OAUG provides its members with education, networking and support via a wide range of activities and forums including conferences, online education, publications, special interest groups and social media. For more information about the OAUG, visit the website at oaug.org or follow OAUG on LinkedIn (OAUG LinkedIn) or Twitter (OAUG Twitter). Contact Information communications@performancearchitects.com Boston, MA, February 17, 2017 --( PR.com )-- Kirby Lunger, Chief Sales and Marketing Officer at Performance Architects, Inc. (www.performancearchitects.com), is joining the board of directors for the OAUG Oracle Business Intelligence & Big Data Special Interest Group (SIG), an affiliated group of the Oracle Applications Users Group (OAUG, www.oaug.org). The purpose of the OAUG Oracle Business Intelligence & Big Data SIG is to provide education and networking opportunities for all Oracle business analytics and big data subject matter and technologies."I am honored to expand my service to the OAUG and Oracle community on the OAUG Oracle Business Intelligence & Big Data SIG board of directors," said Kirby Lunger. “The Performance Architects team works extensively with business analytics and big data initiatives across several industries, and this SIG is a wonderful forum for professional networking and sharing, as well as learning from Oracle product management and marketing, customers, and partners.”“We’re excited to have Kirby join the Board of the Oracle Business Intelligence & Big Data SIG,” said Jay Canupp, Board Chair for the Oracle Business Intelligence & Big Data SIG. “Her industry experience in business analytics, BI and data discovery, coupled with her leadership background in related topic areas at the OAUG, will allow us to continue to expand our reach and grow our relationships within the Oracle community.”About Performance Architects, Inc.Performance Architects, Inc. is a business and technology consulting company that partners with our clients to initiate and sustain significant improvements in enterprise performance. We offer business consulting to help establish and enhance performance management processes either across your organization or within specific functions; technology consulting to make sure that the appropriate data and information are available to make the best decisions to improve performance; and industry expertise to provide the context for what your organization should do to lead within your segment.Performance Architects is a Platinum level and Cloud Standard member of the Oracle PartnerNetwork (OPN), with Specializations in Oracle BI Foundation (BICS), Oracle Essbase, Oracle Hyperion Planning (PBCS), Oracle Hyperion Financial Management (HFM), Oracle Accelerate for Midsize Companies, Education & Research (Higher Education) and Life Sciences. Our team has worked with Oracle EPM (Hyperion) products since these products were launched, and maintains deep experience with the entire Oracle Business Intelligence (OBI) suite and related data discovery solutions.Performance Architects' services in this arena include implementing or augmenting financial applications, reporting and analysis solutions, and underlying technologies both organization-wide or within specific functional areas such as Finance, IT, HR, Sales & Marketing, and Operations. More information about Performance Architects is available at www.performancearchitects.com, or follow Performance Architects on Twitter, Facebook, LinkedIn and YouTube.About the Oracle Applications Users Group (OAUG®)Founded in 1990, the Oracle Applications Users Group (OAUG) is an independent, global, member-led organization that maximizes customers’ investment in Oracle and partner solutions. The organization serves as an advocate to Oracle for companies worldwide and represents users of Oracle Applications products including Oracle Applications Cloud, Oracle E-Business Suite, Oracle Enterprise Performance Management (including Oracle Hyperion), Oracle’s Primavera Enterprise Project Portfolio Management, Oracle Communications, Oracle Customer Experience Cloud, and others. The OAUG provides its members with education, networking and support via a wide range of activities and forums including conferences, online education, publications, special interest groups and social media. For more information about the OAUG, visit the website at oaug.org or follow OAUG on LinkedIn (OAUG LinkedIn) or Twitter (OAUG Twitter).Contact Informationcommunications@performancearchitects.com Click here to view the list of recent Press Releases from Performance Architects, Inc.


News Article | August 22, 2016
Site: cen.acs.org

Crystalline materials, like diamonds or gemstones, are typically hard and brittle. But crystals made of orderly arrangements of organic molecules can be flexible. Although most such crystals have been discovered serendipitously, now researchers have designed organic molecules that form flexible crystals through weak interactions between repeating building blocks (J. Am. Chem. Soc. 2016, DOI: 10.1021/jacs.6b05118). This design principle could be applied to engineer materials for organic solar cells and light-emitting diodes, or as additives to ease pharmaceutical manufacturing, the researchers say. Little is known about how the structure of organic crystals determines their mechanical properties. But C. Malla Reddy of the Indian Institute of Science Education & Research Kolkata and his colleagues started with one known principle: Under mechanical stress, weak connections easily break and reform, sometimes allowing a material to bend without breaking. Harnessing the power of weak interactions, they designed three classes of organic molecules to form different flexible crystals. One such class used building blocks of naphthalene diimides with spherical methyl or t-butyl groups on either end. The aromatic rings in the center of each building block stack one on top of the other to form one dimension of the crystal. Meanwhile, these stacks interact side-to-side through weak, short-lived electrostatic attractions between the alkyl groups. These interactions create planes running through the crystal where the layers can slide past each other when the crystal is bent. Reddy compares this sliding motion to sheets of paper slipping past each other in a bent notepad. Using this flexibility, the researchers could shape the microscopic crystals into letters of the alphabet. For the second class of molecules, the researchers used substituted benzoic acid building blocks held together in one direction with relatively strong hydrogen bonds, commonly used for linking building blocks in crystal engineering. In the other dimension, weak halogen-halogen interactions between chlorine or bromine atoms at the ends of these building blocks created the slipping layers that produced flexibility within this crystal. The researchers made the third class of building blocks out of o-vanillin joined to anilines substituted with halogens or alkoxy groups. This class of molecules forms crystals that change color when illuminated or that propel themselves off a surface when heated—properties that could be useful for applications like optical memory or mechanically active materials. In this case, weak interactions between alkoxy and halogen groups created the slip. A lot of chemical insight is required to produce crystals that can be bent into letters, says Gautam R. Desiraju of the Indian Institute of Science. He calls this an “ideal study” of crystal engineering, in that the researchers used their understanding of how the molecules in a crystal affect its structure and physical properties to design and build the crystal. Reddy hopes other researchers apply weak interactions to designing flexible organic semiconducting molecules or substances to aid pharmaceutical production. When making medicines, active ingredients are often combined with excipient materials as part of the formulation and manufacturing process. But if an excipient makes a powder too brittle, it can break when stirred, creating inconsistent product. Flexible crystals could help solve this problem, Reddy says.

Loading Education & Research collaborators
Loading Education & Research collaborators